| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $83.2M | +51.8% |
| SG&A Expense | $20.8M | +0.0% |
| Operating Income | -$104.0M | -37.5% |
| Income Tax | $0 | — |
| Net Income | -$102.0M | -43.4% |
| EPS (Basic) | -$1.62 | -18.2% |
| EPS (Diluted) | -$1.62 | -18.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.1M | -39.1% |
| Short-term Investments | $92.0M | -40.3% |
| Current Assets | $120.7M | -38.5% |
| Total Assets | $123.2M | -38.7% |
| Current Liabilities | $33.9M | +130.8% |
| Long-term Debt | $31.5M | -29.7% |
| Total Liabilities | $65.4M | +8.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$91.9M | -30.0% |
| Capital Expenditures | $62K | -79.2% |
| Investing Cash Flow | $67.0M | +224.9% |
| Financing Cash Flow | $11.4M | -91.0% |
| Free Cash Flow | -$92.0M | -29.6% |
| Stockholders' Equity |
| $57.8M |
| -58.8% |